These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 29308536)

  • 21. Antitumor activity of Lobaplatin against esophageal squamous cell carcinoma through caspase-dependent apoptosis and increasing the Bax/Bcl-2 ratio.
    Du L; Fei Z; Song S; Wei N
    Biomed Pharmacother; 2017 Nov; 95():447-452. PubMed ID: 28865364
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Down-regulation of Rictor enhances cell sensitivity to PI3K inhibitor LY294002 by blocking mTORC2-medicated phosphorylation of Akt/PRAS40 in esophageal squamous cell carcinoma.
    Hou G; Zhao Q; Zhang M; Fan T; Liu M; Shi X; Ren Y; Wang Y; Zhou J; Lu Z
    Biomed Pharmacother; 2018 Oct; 106():1348-1356. PubMed ID: 30119206
    [TBL] [Abstract][Full Text] [Related]  

  • 23. OP16, a novel ent-kaurene diterpenoid, potentiates the antitumor effect of rapamycin by inhibiting rapamycin-induced feedback activation of Akt signaling in esophageal squamous cell carcinoma.
    Peng KZ; Ke Y; Zhao Q; Tian F; Liu HM; Hou G; Lu Z
    Biochem Pharmacol; 2017 Sep; 140():16-27. PubMed ID: 28539264
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Remarkable inhibition effects of afatinib alone or combining with paclitaxel in esophageal squamous cell carcinoma.
    Yang LY; Cheng ZJ; Liu Z; Wang D; Zhang N; Fan ZL; Cai HQ; Zhang Y; Cai Y; Xu X; Wang JH; Du GH; Hao JJ; Wang MR
    J Gastroenterol Hepatol; 2021 Sep; 36(9):2513-2522. PubMed ID: 33721913
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Astaxanthin increases radiosensitivity in esophageal squamous cell carcinoma through inducing apoptosis and G2/M arrest.
    Qian X; Tan C; Yang B; Wang F; Ge Y; Guan Z; Cai J
    Dis Esophagus; 2017 Jun; 30(6):1-7. PubMed ID: 28475750
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Purpurogallin is a novel mitogen-activated protein kinase kinase 1/2 inhibitor that suppresses esophageal squamous cell carcinoma growth in vitro and in vivo.
    Xie X; Zu X; Liu F; Wang T; Wang X; Chen H; Liu K; Wang P; Liu F; Zheng Y; Bode AM; Dong Z; Kim DJ
    Mol Carcinog; 2019 Jul; 58(7):1248-1259. PubMed ID: 31100197
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Huang-lian-jie-du-tang, a traditional Chinese medicine prescription, induces cell-cycle arrest and apoptosis in human liver cancer cells in vitro and in vivo.
    Hsu YL; Kuo PL; Tzeng TF; Sung SC; Yen MH; Lin LT; Lin CC
    J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 2):e290-9. PubMed ID: 18522681
    [TBL] [Abstract][Full Text] [Related]  

  • 28. AR-42: A Pan-HDAC Inhibitor with Antitumor and Antiangiogenic Activities in Esophageal Squamous Cell Carcinoma.
    Zhu Y; Yuan T; Zhang Y; Shi J; Bai L; Duan X; Tong R; Zhong L
    Drug Des Devel Ther; 2019; 13():4321-4330. PubMed ID: 31908417
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The identification of the ATR inhibitor VE-822 as a therapeutic strategy for enhancing cisplatin chemosensitivity in esophageal squamous cell carcinoma.
    Shi Q; Shen LY; Dong B; Fu H; Kang XZ; Yang YB; Dai L; Yan WP; Xiong HC; Liang Z; Chen KN
    Cancer Lett; 2018 Sep; 432():56-68. PubMed ID: 29890208
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Jaridonin-induced G2/M phase arrest in human esophageal cancer cells is caused by reactive oxygen species-dependent Cdc2-tyr15 phosphorylation via ATM-Chk1/2-Cdc25C pathway.
    Ma YC; Su N; Shi XJ; Zhao W; Ke Y; Zi X; Zhao NM; Qin YH; Zhao HW; Liu HM
    Toxicol Appl Pharmacol; 2015 Jan; 282(2):227-36. PubMed ID: 25450480
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pseudolaric Acid B Inhibits Proliferation, Invasion, and Angiogenesis in Esophageal Squamous Cell Carcinoma Through Regulating CD147.
    Yin Z; Cai H; Wang Z; Jiang Y
    Drug Des Devel Ther; 2020; 14():4561-4573. PubMed ID: 33149553
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oroxylin a could be a Promising Radiosensitizer for Esophageal Squamous Cell Carcinoma by Inducing G2/M Arrest and Activating Apoptosis.
    Tan C; Qian X; Ge Y; Yang B; Wang F; Guan Z; Cai J
    Pathol Oncol Res; 2017 Apr; 23(2):323-328. PubMed ID: 27585443
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anticancer effects of suberoylanilide hydroxamic acid in esophageal squamous cancer cells in vitro and in vivo.
    Tzao C; Jin JS; Chen BH; Chung HY; Chang CC; Hsu TY; Sun GH
    Dis Esophagus; 2014; 27(7):693-702. PubMed ID: 24033428
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Soft Coral-Derived Compound, 11-Dehydrosinulariolide, Induces G2/M Cell Cycle Arrest and Apoptosis in Small Cell Lung Cancer.
    Lin YC; Su JH; Lin SC; Chang CC; Hsia TC; Tung YT; Lin CC
    Mar Drugs; 2018 Nov; 16(12):. PubMed ID: 30513611
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Scutellarin Suppresses Patient-Derived Xenograft Tumor Growth by Directly Targeting AKT in Esophageal Squamous Cell Carcinoma.
    Liu F; Zu X; Xie X; Zhang Y; Liu K; Chen H; Wang T; Bode AM; Dong Z; Kim DJ
    Cancer Prev Res (Phila); 2019 Dec; 12(12):849-860. PubMed ID: 31554627
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Plumbagin, a natural naphthoquinone, inhibits the growth of esophageal squamous cell carcinoma cells through inactivation of STAT3.
    Cao Y; Yin X; Jia Y; Liu B; Wu S; Shang M
    Int J Mol Med; 2018 Sep; 42(3):1569-1576. PubMed ID: 29901084
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neferine induces apoptosis by modulating the ROS‑mediated JNK pathway in esophageal squamous cell carcinoma.
    An K; Zhang Y; Liu Y; Yan S; Hou Z; Cao M; Liu G; Dong C; Gao J; Liu G
    Oncol Rep; 2020 Sep; 44(3):1116-1126. PubMed ID: 32705225
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ovatodiolide isolated from Anisomeles indica induces cell cycle G2/M arrest and apoptosis via a ROS-dependent ATM/ATR signaling pathways.
    Yu CY; Jerry Teng CL; Hung PS; Cheng CC; Hsu SL; Hwang GY; Tzeng YM
    Eur J Pharmacol; 2018 Jan; 819():16-29. PubMed ID: 28986085
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Potential therapeutic effect of targeting glycogen synthase kinase 3β in esophageal squamous cell carcinoma.
    Bolidong D; Domoto T; Uehara M; Sabit H; Okumura T; Endo Y; Nakada M; Ninomiya I; Miyashita T; Wong RW; Minamoto T
    Sci Rep; 2020 Jul; 10(1):11807. PubMed ID: 32678196
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Osthole inhibits the PI3K/AKT signaling pathway via activation of PTEN and induces cell cycle arrest and apoptosis in esophageal squamous cell carcinoma.
    Zhu X; Li Z; Li T; Long F; Lv Y; Liu L; Liu X; Zhan Q
    Biomed Pharmacother; 2018 Jun; 102():502-509. PubMed ID: 29579711
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.